Name | Teriparatide acetate hydrate |
---|---|
Synonyms | MFCD01775001 |
Description | Teriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) is a PHT agonist. Teriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) can be used for osteoporosis research[1]. |
---|---|
Related Catalog | |
In Vivo | Teriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) (20 μg/kg, i.h.; daily, for 4 weeks; female New Zealand white rabbits) increases the cortical thickness and porosity[1]. Animal Model: Female New Zealand white rabbits[1] Dosage: 20 μg/kg Administration: Subcutaneous injection; daily, for 4 weeks Result: Increased the pore ratio, number, and density as well as the cortical area, thickness, and bone mineral content (BMC), without significant influencing the volumetric bone mineral density (BMD). |
References |
Molecular Formula | C181H291N55O51S2.x(C2H4O2).x(H2O) |
---|---|
Molecular Weight | 4177.83 |
Storage condition | -20°C |
Hazard Codes | Xi |
---|